
Athersys ATHX
Quartalsbericht 2023-Q3
hinzugefügt 16.11.2023
Athersys EV/EBITDA 2011-2026 | ATHX
EV/EBITDA Jährlich Athersys
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.437 | -4.03 | -3.93 | -6.59 | -5.25 | -5.4 | -4.34 | -4.71 | -7.96 | -1.29 | -2.55 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 0.437 | -7.96 | -4.15 |
EV/EBITDA anderer Aktien in der Pharmaeinzelhändler
| Name | EV/EBITDA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
-0.591 | - | 2.43 % | $ 254 M | ||
|
Acer Therapeutics
ACER
|
-3.39 | - | 2.71 % | $ 14 M | ||
|
AbbVie
ABBV
|
11.9 | $ 232.08 | 3.29 % | $ 411 B | ||
|
AbCellera Biologics
ABCL
|
9.24 | $ 3.61 | 0.56 % | $ 1.08 B | ||
|
Abeona Therapeutics
ABEO
|
0.0546 | $ 5.12 | -1.54 % | $ 109 M | ||
|
Arbutus Biopharma Corporation
ABUS
|
-3.41 | $ 4.66 | -0.85 % | $ 773 M | ||
|
ACADIA Pharmaceuticals
ACAD
|
-21.1 | $ 24.56 | -0.32 % | $ 4.07 B | ||
|
I-Mab
IMAB
|
595 | - | - | $ 866 M | ||
|
Achieve Life Sciences
ACHV
|
1.23 K | $ 4.56 | -3.59 % | $ 90.4 M | ||
|
AC Immune SA
ACIU
|
-3.79 | $ 2.93 | -1.01 % | $ 229 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
10.7 | - | - | $ 40.3 B | ||
|
AgeX Therapeutics
AGE
|
-1.85 | - | -10.17 % | $ 12.2 K | ||
|
Aclaris Therapeutics
ACRS
|
-9.24 | $ 2.87 | -8.31 % | $ 352 M | ||
|
Biophytis SA
BPTS
|
-17.6 | - | -13.47 % | $ 169 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-4.27 | - | - | $ 1.01 B | ||
|
Adagene
ADAG
|
-4.92 | $ 2.96 | -4.67 % | $ 167 M | ||
|
ADC Therapeutics SA
ADCT
|
-4.34 | $ 4.1 | -0.73 % | $ 105 M | ||
|
Adial Pharmaceuticals
ADIL
|
-1.82 | $ 2.53 | - | $ 16.4 M | ||
|
ADMA Biologics
ADMA
|
-4.17 | $ 15.57 | 2.57 % | $ 3.71 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
0.546 | - | - | $ 26.5 M | ||
|
Adaptive Biotechnologies Corporation
ADPT
|
-10.9 | $ 16.02 | -2.67 % | $ 2.43 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.42 | - | -1.52 % | $ 24.7 M | ||
|
ADiTx Therapeutics
ADTX
|
0.0334 | $ 0.46 | -4.63 % | $ 6.06 K | ||
|
Midatech Pharma plc
MTP
|
0.796 | - | -18.52 % | $ 27.3 M | ||
|
Agenus
AGEN
|
-8.96 | $ 3.33 | -0.89 % | $ 1.19 M | ||
|
Agios Pharmaceuticals
AGIO
|
-5.08 | $ 30.23 | 0.83 % | $ 1.75 B | ||
|
AIM ImmunoTech
AIM
|
1.77 | $ 0.91 | -8.59 % | $ 43.8 M | ||
|
Akebia Therapeutics
AKBA
|
-2.4 | $ 1.31 | -0.76 % | $ 337 M | ||
|
Akari Therapeutics, Plc
AKTX
|
-249 | $ 0.24 | -8.87 % | $ 5.73 B | ||
|
ARCA biopharma
ABIO
|
1.84 | - | 1052.0 % | $ 415 M | ||
|
Acorda Therapeutics
ACOR
|
0.777 | - | -24.86 % | $ 820 K | ||
|
Acasti Pharma
ACST
|
1.8 | - | 4.01 % | $ 150 M | ||
|
Aldeyra Therapeutics
ALDX
|
0.72 | $ 5.46 | -0.73 % | $ 328 M | ||
|
Alector
ALEC
|
-44.8 | $ 2.43 | -5.08 % | $ 250 M | ||
|
Aligos Therapeutics
ALGS
|
-2.41 | $ 7.03 | -6.27 % | $ 452 M | ||
|
Adverum Biotechnologies
ADVM
|
-1.32 | - | - | $ 86.2 M | ||
|
Alkermes plc
ALKS
|
86.6 | $ 30.1 | -2.05 % | $ 4.96 B | ||
|
Институт стволовых клеток человека
ISKJ
|
14 | - | - | - | ||
|
Allogene Therapeutics
ALLO
|
-7.54 | $ 2.78 | 1.83 % | $ 436 M | ||
|
AIkido Pharma
AIKI
|
-45.5 | - | 1.93 % | $ 17.4 M | ||
|
Alnylam Pharmaceuticals
ALNY
|
-31.5 | $ 332.92 | 0.51 % | $ 43.6 B | ||
|
Akero Therapeutics
AKRO
|
-4.64 | - | - | $ 3.67 B | ||
|
Akouos
AKUS
|
-1.13 | - | 0.23 % | $ 488 M | ||
|
Altimmune
ALT
|
-1.66 | $ 4.31 | -3.36 % | $ 306 M | ||
|
Albireo Pharma
ALBO
|
-3.38 | - | -0.23 % | $ 916 M | ||
|
ALX Oncology Holdings
ALXO
|
-5.99 | $ 2.11 | -10.21 % | $ 110 M | ||
|
Allena Pharmaceuticals
ALNA
|
0.298 | - | 3.16 % | $ 1.9 M | ||
|
Amgen
AMGN
|
10.7 | $ 388.16 | 2.33 % | $ 209 B | ||
|
Aileron Therapeutics
ALRN
|
-0.0369 | - | 10.36 % | $ 9.8 M | ||
|
AlloVir
ALVR
|
-3.61 | - | 4.14 % | $ 49.1 M |